Literature DB >> 1699782

Frequency of variant antigens in Giardia lamblia.

T E Nash1, S M Banks, D W Alling, J W Merritt, J T Conrad.   

Abstract

Giardia lamblia undergoes antigenic variation. The rate of antigenic variation and the size of the variant antigen repertoire were estimated in clones of Giardia lamblia which reexpresses surface variant antigens that are characteristics of its parent. Calculations were based on determinations of the number of trophozoites expressing defined or nondefined epitopes as well as the total number of trophozoites in newly established clones. The rate of appearance of variant antigens containing defined epitopes was expressed as the number of generations until the first trophozoite expressing a defined epitope appeared. In clones of isolate WB, tested because their major surface variant antigens were largely nondefined, variants expressing epitopes recognized by Mabs 6E7 or 3F6 appeared after approximately 12 generations. Variants expressing epitopes recognized by Mab 5C1 appeared at about 13 generations, significantly greater than for the other epitopes. The rate of antigenic variation was studied in another isolate, GS/M, whose surface epitope repertoire differs from that of isolate WB. A single epitope recognized by Mab G10/4 was tested. Trophozoites reexpressing this epitope first appeared after about 6.5 generations, significantly less than in WB. Therefore, the single epitope studied in isolate GS/M is reexpressed much more frequently than those of WB. In isolate WB, the epitopes recognized by Mab 6E7 and 3F6 tended to appear at the same time. The median number of variant antigens in WB was estimated to lie between 20.5 and 184.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699782     DOI: 10.1016/0014-4894(90)90067-m

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  26 in total

1.  Variant-specific surface protein switching in Giardia lamblia.

Authors:  T E Nash; H T Luján; M R Mowatt; J T Conrad
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Biology of Giardia lamblia.

Authors:  R D Adam
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens.

Authors:  Jeffrey W Priest; Delynn M Moss; Govinda S Visvesvara; Cara C Jones; Anna Li; Judith L Isaac-Renton
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

Review 4.  Immune response to Giardia duodenalis.

Authors:  G Faubert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  A microRNA derived from an apparent canonical biogenesis pathway regulates variant surface protein gene expression in Giardia lamblia.

Authors:  Ashesh A Saraiya; Wei Li; Ching C Wang
Journal:  RNA       Date:  2011-10-27       Impact factor: 4.942

6.  Cytokines, Antibodies, and Histopathological Profiles during Giardia Infection and Variant-Specific Surface Protein-Based Vaccination.

Authors:  Marianela C Serradell; Pablo R Gargantini; Alicia Saura; Sergio R Oms; Lucía L Rupil; Luciana Berod; Tim Sparwasser; Hugo D Luján
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

7.  The cysteine-rich protein gene family of Giardia lamblia: loss of the CRP170 gene in an antigenic variant.

Authors:  R D Adam; Y M Yang; T E Nash
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Variant surface antigens of Giardia lamblia are associated with the presence of a thick cell coat: thin section and label fracture immunocytochemistry survey.

Authors:  P F Pimenta; P P da Silva; T Nash
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 9.  The biology of Giardia spp.

Authors:  R D Adam
Journal:  Microbiol Rev       Date:  1991-12

10.  Allele-specific expression of a variant-specific surface protein (VSP) of Giardia lamblia.

Authors:  Y Yang; R D Adam
Journal:  Nucleic Acids Res       Date:  1994-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.